Hua Kun, Nie Yu, Hou Jianfeng, Zheng Zhe, Hu Shengshou
State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, People's Republic of China.
Cell Biol Int. 2014 Sep;38(9):1032-40. doi: 10.1002/cbin.10307. Epub 2014 Jun 16.
One of the most important indicators of myocardial regeneration is cardiomyocyte proliferation. However, it is difficult to distinguish cardiomyocytes in the regenerating stage from binucleated or multinucleated myocytes by conventional morphometric techniques. As cell cycle progression (CCP) scores have been successfully applied to the evaluation of the proliferation of cancer cells, we sought to establish a multi-gene score to evaluate cardiomyocyte proliferation in this study. Given the disturbances of nuclear division without cell division that occurs in cardiomyocytes, ten cytokinesis-correlated genes (Anln, Aurkb, Cenpa, Kif4, Kif23, Prc1, RhoA, Spin1, TACC2, and CDC42) were chosen to establish the cardiomyocyte cytokinesis score (CC-Score). The expression levels of these genes in H9C2 rat cardiomyoblast cells, the proliferation of which were stimulated or inhibited, were detected using qRT-PCR. To confirm the feasibility of the CC-Score system, four conventional methods for evaluating cardiomyocyte proliferation, including the MTT assay, BrdU assay, immunofluorescence, and flow cytometry analysis, were used in each group. The results of the CC-Score in the assessment of the proliferation of H9C2 cells were consistent with those of four commonly used proliferative assay methods. We conclude that the CC-Score can be used to assess the proliferation status of H9C2 cells, and suggest that the CC-Score may be a potential method for the assessment of cardiomyocyte proliferation in myocardial regeneration. However, validation studies utilizing primary cultured rat cardiomyocytes and heart tissue are warranted.
心肌再生最重要的指标之一是心肌细胞增殖。然而,通过传统的形态测量技术很难区分再生阶段的心肌细胞与双核或多核心肌细胞。由于细胞周期进程(CCP)评分已成功应用于癌细胞增殖的评估,因此在本研究中我们试图建立一个多基因评分来评估心肌细胞增殖。鉴于心肌细胞中会发生无细胞分裂的核分裂紊乱,我们选择了十个与胞质分裂相关的基因(Anln、Aurkb、Cenpa、Kif4、Kif23、Prc1、RhoA、Spin1、TACC2和CDC42)来建立心肌细胞胞质分裂评分(CC评分)。使用qRT-PCR检测这些基因在增殖受到刺激或抑制的H9C2大鼠心肌母细胞中的表达水平。为了证实CC评分系统的可行性,每组使用了四种评估心肌细胞增殖的传统方法,包括MTT法、BrdU法、免疫荧光法和流式细胞术分析。CC评分在评估H9C2细胞增殖方面的结果与四种常用增殖检测方法一致。我们得出结论,CC评分可用于评估H9C2细胞的增殖状态,并表明CC评分可能是评估心肌再生中心肌细胞增殖的一种潜在方法。然而,需要利用原代培养的大鼠心肌细胞和心脏组织进行验证研究。